Subscribe To
NUVA / NuVasive, Inc. (NUVA) Q3 2022 - Earnings Call Transcript
NUVA News
By Seeking Alpha
May 10, 2023
NuVasive, Inc. (NUVA) Q1 2023 Earnings Call Transcript
NuVasive, Inc. (NASDAQ:NUVA ) Q1 2023 Earnings Conference Call May 10, 2023 4:30 PM ET Company Participants Juliet Cunningham - Vice President, Invest more_horizontal
By Seeking Alpha
May 4, 2023
Globus Medical: Still Very Attractive After NuVasive Selloff
Globus Medical caught headlines after announcing the NuVasive merger. Investors have wiped out considerable equity post-announcement, but the worst ma more_horizontal
By Zacks Investment Research
May 1, 2023
Is NuVasive (NUVA) a Great Value Stock Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Neverthe more_horizontal
By Zacks Investment Research
April 25, 2023
NUVA vs. ABT: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Products sector might want to consider either NuVasive (NUVA) or Abbott (ABT). But which of these two st more_horizontal
By Zacks Investment Research
March 24, 2023
Why Is NuVasive (NUVA) Down 15.9% Since Last Earnings Report?
NuVasive (NUVA) reported earnings 30 days ago. What's next for the stock? more_horizontal
By Zacks Investment Research
March 21, 2023
NuVasive's (NUVA) Precice System Cleared for Pediatric Patients
NuVasive (NUVA) receives FDA 510(k) clearance for using the Precice limb lengthening system for treating pediatric patients. more_horizontal
By Zacks Investment Research
March 17, 2023
NuVasive (NUVA), GMED Merger Aids, Macro Woes Mar Growth
According to NuVasive (NUVA), the combined company is set to have an advanced commercial scale and portfolio of clinically proven solutions. more_horizontal
By Zacks Investment Research
March 2, 2023
Bear of the Day: NuVasive (NUVA)
Softer results for spinal surgery innovator plus questionable merger have dropped estimates and shares more_horizontal